Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1993;87:1897-1906

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hook, B. G.
Right arrow Articles by Marchlinski, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hook, B. G.
Right arrow Articles by Marchlinski, F. E.

Circulation, Vol 87, 1897-1906, Copyright © 1993 by American Heart Association


ARTICLES

Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Rhythm diagnosis and management aided by stored electrogram analysis

BG Hook, DJ Callans, RB Kleiman, BT Flores and FE Marchlinski
Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia 19104.

BACKGROUND. This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms before implantable cardioverter- defibrillator (ICD) therapy. METHODS AND RESULTS. The study population included 48 patients who received the Cadence Tiered Therapy Defibrillator System, an investigational third-generation ICD with ventricular electrogram storage capabilities. Criteria for arrhythmia diagnosis were based on analysis of the electrogram rate, RR interval variability, and morphology. Twenty-nine of the 48 patients (60%) experienced at least one episode of antitachycardia pacing or shock (one shock or more in 25 of 29 patients) that was preceded by minimal or no symptoms during a mean follow-up of 15.1 +/- 7.8 months. There were 194 tachycardia episodes registered by the device, including 101 for which ventricular electrograms were stored and available for analysis. Of the 101 stored electrograms, 74 were classified as ventricular tachycardia (VT), 24 as non-VT rhythms (atrial fibrillation, 13; supraventricular tachycardia, six; rate-sensing lead disruption, four; T wave oversensing, one), and only three as indeterminate rhythms. Based on the electrogram analysis, changes in tachycardia detection criteria and/or antiarrhythmic drug regimens were implemented and were associated with a reduction in the number of device responses for non-VT rhythms from 24 during the initial study period to three during 11.0 +/- 7.2 months of additional follow-up. CONCLUSIONS. ICD responses in the absence of symptoms are relatively common in third-generation devices with antitachycardia pacing capabilities. Despite potential limitations such as the effect of bundle branch block on the electrogram morphology during supraventricular tachycardia, the availability of electrogram storage capabilities allowed a presumptive diagnosis of the events precipitating asymptomatic device responses. Device reprogramming based on analysis of stored electrograms was associated with a dramatic reduction in the incidence of ICD responses for non-VT rhythms.


This article has been cited by other articles:


Home page
CirculationHome page
J. Almendral and M. E. Josephson
All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator
Circulation, September 4, 2007; 116(10): 1204 - 1212.
[Full Text] [PDF]


Home page
EuropaceHome page
A. Quesada, J.ús Almendral, F. Arribas, R. Ricci, C. Wolpert, P. Adragao, E. Cobo, X. Navarro, and on behalf DATAS investigators
The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator
Europace, January 1, 2004; 6(2): 142 - 150.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
F. Duru, U. Bauersfeld, and R. Candinas
Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion
Europace, January 1, 2001; 3(1): 80 - 84.
[Abstract] [PDF]


Home page
EuropaceHome page
S. Nisam
A Prophylactic ICD? Who are the patients? What is the device?
Europace, January 1, 2001; 3(4): 269 - 274.
[PDF]


Home page
J Am Coll CardiolHome page
N. P. Andrews, R. I. Fogel, G. Pelargonio, J. J. Evans, and E. N. Prystowsky
Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: A comparison with patients known to have sustained ventricular tachycardia
J. Am. Coll. Cardiol., December 1, 1999; 34(7): 2023 - 2030.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.M Pratt, A.J Camm, J.T Bigger Jr, G Breithardt, R.W.F Campbell, A.E Epstein, L.J Kappenberger, K.-H Kuck, S Pocock, S Saksena, et al.
Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?
Eur. Heart J., November 1, 1999; 20(21): 1538 - 1552.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
A. Pacifico, L. L. Ferlic, F.e. R. Cedillo-Salazar, N. Nasir Jr, T. K. Doyle, and P. D. Henry
Shocks as predictors of survival in patients with implantable cardioverter-defibrillators
J. Am. Coll. Cardiol., July 1, 1999; 34(1): 204 - 210.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. A. Pires, M. H. Lehmann, R. T. Steinman, J. J. Baga, C. D. Schuger, and Participating Investigators
Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 24 - 32.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Ruppel, C. A. Schluter, S. Boczor, T. Meinertz, M. Schluter, K.-H. Kuck, and R. Cappato
Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators
J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1724 - 1730.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Schaumann, F. v. z. Muhlen, B. Herse, B.-D. Gonska, and H. Kreuzer
Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators : A Prospective Study Including 200 Patients
Circulation, January 13, 1998; 97(1): 66 - 74.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Epstein, W. M. Miles, D. G. Benditt, A. J. Camm, E. J. Darling, P. L. Friedman, A. Garson, J. C. Harvey, G. A. Kidwell, G. J. Klein, et al.
Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology
Circulation, September 1, 1996; 94(5): 1147 - 1166.
[Full Text]


Home page
CirculationHome page
J. Villacastin, J. Almendral, A. Arenal, J. Albertos, J. Ormaetxe, R. Peinado, H. Bueno, J. L. Merino, A. Pastor, O. Medina, et al.
Incidence and Clinical Significance of Multiple Consecutive, Appropriate, High-Energy Discharges in Patients With Implanted Cardioverter-Defibrillators
Circulation, February 15, 1996; 93(4): 753 - 762.
[Abstract] [Full Text]